ArticleLeukemia research reports2022

Daratumumab triplet therapies in patients with relapsed or refractory multiple myeloma: A "real world" experience.

Ludovica Fucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.